Mark Liu

649 total citations
32 papers, 459 citations indexed

About

Mark Liu is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology. According to data from OpenAlex, Mark Liu has authored 32 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Physiology and 7 papers in Immunology. Recurrent topics in Mark Liu's work include Asthma and respiratory diseases (7 papers), Microbial Natural Products and Biosynthesis (4 papers) and Immune responses and vaccinations (4 papers). Mark Liu is often cited by papers focused on Asthma and respiratory diseases (7 papers), Microbial Natural Products and Biosynthesis (4 papers) and Immune responses and vaccinations (4 papers). Mark Liu collaborates with scholars based in United States, Italy and United Kingdom. Mark Liu's co-authors include Mary Haak‐Frendscho, Bradley J. Undem, Axel Fischer, Scott V. Edwards, Miguel Alcaide, CHAO-MIN LIU, Simon D. van Haren, Ofer Levy, P. Miller and Al Ozonoff and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Mark Liu

29 papers receiving 449 citations

Peers

Mark Liu

IMMUN

PHYSI

CMN

Mariko Ito Japan

Kazuya Kobayashi Japan

Michael J. Fields United States

Elizabeth Browne United States

Gabriela Krejčová Czechia

Ippei Sakakibara Japan

Rui-Ting Li China

Hongmei Liu China

K. Matsubayashi Japan

J.L. Dutton Australia

Mariko Ito Japan

Mark Liu

86 ×0.6

IMMUN

164 ×1.8

47 ×0.6

PHYSI

75 ×1.1

CMN

35 ×0.6

Citations per year, relative to Mark Liu Mark Liu (= 1×) peers Mariko Ito

Countries citing papers authored by Mark Liu

Since Specialization

Citations

This map shows the geographic impact of Mark Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Liu more than expected).

Fields of papers citing papers by Mark Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Liu. The network helps show where Mark Liu may publish in the future.

Co-authorship network of co-authors of Mark Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Liu. A scholar is included among the top collaborators of Mark Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Liu. Mark Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shaw, Andrew, et al.. (2023). Bioequivalence Studies of Sildenafil Citrate Orodispersible Film Administered with and without Water vs ViagraⓇ Film-Coated Tablets in Healthy Male Volunteers. Current Therapeutic Research. 99. 100708–100708. 2 indexed citations

Xue, Wei, et al.. (2023). The Comparative Bioavailability of Fluticasone and Azelastine Delivered as a Single Fixed Dose Combination (MP-AzeFlu) in Comparison to Two Different Formulations of Azelastine and Fluticasone Propionate Following Intranasal Administration in Healthy Chinese Volunteers. Journal of Asthma and Allergy. Volume 16. 667–677.

Bird, Lina J., Arkadiy I. Garber, Yuichi Hongoh, et al.. (2023). Insights into the physiological and genomic characterization of three bacterial isolates from a highly alkaline, terrestrial serpentinizing system. Frontiers in Microbiology. 14. 1179857–1179857. 2 indexed citations

Owen, Joel, Matthew A. Hummel, Stefan Roepcke, et al.. (2023). Population Pharmacokinetics of MYL-1402O, a Proposed Biosimilar to Bevacizumab and Reference Product (Avastin®) in Patients with Non-squamous Non-small Cell Lung Cancer. European Journal of Drug Metabolism and Pharmacokinetics. 48(6). 675–689. 1 indexed citations

Liu, Mark, Diego Bagnasco, Andrea Matucci, et al.. (2023). Real World Benefits of Mepolizumab in Patients With Severe Asthma and Comorbid Chronic Rhinosinusitis With Nasal Polyps (CRSwNP): Post Hoc Analysis of REALITI-A. Journal of Allergy and Clinical Immunology. 151(2). AB15–AB15. 1 indexed citations

Lee, Jason T., Mark Liu, Florence Schleich, et al.. (2023). Real-World Benefits of Mepolizumab in Patients With Overlapping Allergic and Eosinophilic Endophenotypes: Post Hoc Analysis of REALITI-A by Omalizumab Eligibility. Journal of Allergy and Clinical Immunology. 151(2). AB21–AB21. 1 indexed citations

Haren, Simon D. van, Gabriel Kristian Pedersen, Azad Kumar, et al.. (2022). CAF08 adjuvant enables single dose protection against respiratory syncytial virus infection in murine newborns. Nature Communications. 13(1). 4234–4234. 20 indexed citations

Diray‐Arce, Joann, Asimenia Angelidou, Kristoffer Jarlov Jensen, et al.. (2022). Bacille Calmette-Guérin vaccine reprograms human neonatal lipid metabolism in vivo and in vitro. Cell Reports. 39(5). 110772–110772. 18 indexed citations

Bernstein, David, Mark Liu, Florence Schleich, et al.. (2022). The Impact Of Baseline Exhaled Nitric Oxide Levels And Blood Eosinophil Count On Clinical Outcomes In REALITI-A. Journal of Allergy and Clinical Immunology. 149(2). AB189–AB189. 1 indexed citations

10.

Liu, Mark, et al.. (2021). Torsades de pointes in the PACU after outpatient endoscopy: a case report. BMC Anesthesiology. 21(1). 302–302. 1 indexed citations

11.

Liu, Mark, et al.. (2021). Role of the otolaryngologist in nasopharyngeal swab training: A case report and review of the literature. SHILAP Revista de lepidopterología. 20. 100316–100316. 1 indexed citations

12.

Angelidou, Asimenia, Joann Diray‐Arce, Maria Giulia Conti, et al.. (2021). Human Newborn Monocytes Demonstrate Distinct BCG-Induced Primary and Trained Innate Cytokine Production and Metabolic Activation In Vitro. Frontiers in Immunology. 12. 674334–674334. 16 indexed citations

13.

Nathan, Robert A., Louis‐Philippe Boulet, Huib A.M. Kerstjens, et al.. (2020). CAPTAIN STUDY: EFFECT OF BASELINE LUNG FUNCTION ON RESPONSE TO TRIPLE THERAPY IN PATIENTS WITH ASTHMA INADEQUATELY CONTROLLED ON INHALED CORTICOSTEROID/LONG-ACTING BETA2-AGONIST THERAPY. CHEST Journal. 158(4). A2621–A2625.

14.

Angelidou, Asimenia, Maria Giulia Conti, Joann Diray‐Arce, et al.. (2020). Licensed Bacille Calmette-Guérin (BCG) formulations differ markedly in bacterial viability, RNA content and innate immune activation. Vaccine. 38(9). 2229–2240. 64 indexed citations

15.

Liu, Mark, et al.. (2019). Non-depolarizing Neuromuscular Blockers. StatPearls.

16.

Lambert, Allison, Enid Neptune, Robert H. Brown, et al.. (2015). Angiotensin Receptor Blockade Treatment for COPD: Phase II Trial. CHEST Journal. 148(4). 744A–744A. 3 indexed citations

17.

Ortega, Héctor, Mark Liu, Ian Pavord, et al.. (2014). Late-breaking abstract: Reduction in exacerbations with mepolizumab in severe eosinophilic asthma: MENSA study. European Respiratory Journal. 44(Suppl 58). 2906–2906. 1 indexed citations

18.

Undem, Bradley J., et al.. (1999). Allergen–Induced Sensory Neuroplasticity in Airways. International Archives of Allergy and Immunology. 118(2-4). 150–153. 112 indexed citations

19.

LIU, CHAO-MIN, et al.. (1993). Three Novel polyether antibiotics X-14889A, C, and D from a streptomycete. Taxonomy of the producing ogranism, fermentation production and biological properties of the antibiotics.. The Journal of Antibiotics. 46(2). 275–279. 7 indexed citations

20.

LIU, CHAO-MIN, THERON E. HERMANN, Mark Liu, et al.. (1981). Novel poryether antibiotics X-14667A and X-14667B from Streptomyces cinnamonensis subsp. urethanofaciens Discovery, fermentation, biological as well as ionophore properties and taxonomy of the producing culture.. The Journal of Antibiotics. 34(10). 1241–1247. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact